EUVIMEDEUVIMED entdecken
Crossref

Advancing Access to Cell and Gene Therapies in Medicaid

Joseph T Kannarkat, Inmaculada Hernandez, Natasha Parekh

JAMA · 2024

DOI: 10.1001/jama.2024.6224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Joseph T Kannarkat und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Maryland, Baltimore. Hauptthemen laut MEDLINE: Cell- and Tissue-Based Therapy, Genetic Therapy, Health Services Accessibility, Medicaid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Viewpoint presents the components of the payment model and the implementation challenges among the Center for Medicare and Medicaid Innovation, state Medicaid agencies, patients, and manufacturers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell- and Tissue-Based TherapyGenetic TherapyHealth Services AccessibilityMedicaidHumansUnited States

Autor:innen und Institutionen

  • School of Medicine, University of Maryland, Baltimore.
  • Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla.
  • Marathon Health, Indianapolis, Indiana.

Zitieren

APA

Kannarkat, J. T., Hernandez, I., & Parekh, N. (2024). Advancing Access to Cell and Gene Therapies in Medicaid. JAMA. https://doi.org/10.1001/jama.2024.6224

Vancouver

Kannarkat JT, Hernandez I, Parekh N. Advancing Access to Cell and Gene Therapies in Medicaid. JAMA. 2024. doi:10.1001/jama.2024.6224

BibTeX
@article{Kannarkat2024,
  author = {Kannarkat, Joseph T and Hernandez, Inmaculada and Parekh, Natasha},
  title = {Advancing Access to Cell and Gene Therapies in Medicaid},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.6224}
}
Kostenlos starten →